Literature DB >> 21612509

Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia.

Abdulkader F Tawfik1, Abdulaziz M Alswailem, Atef M Shibl, Mohamed H M Al-Agamy.   

Abstract

The prevalence and genetic basis of extended-spectrum beta-lactamases (ESBLs) in Klebsiella pneumoniae remains unclear in Saudi Arabia. Therefore, this study was devoted to determine the prevalence and characterize ESBL-producing K. pneumoniae in Al-Qassim area, Saudi Arabia. A total of 430 isolates of K. pneumoniae isolated from clinical samples were collected over 6 months from January to June 2008. These isolates were screened for the presence of ESBLs by double-disk synergy test and re-evaluated by E-test ESBL method. Minimum inhibitory concentrations of 15 antibiotics against ESBL-positive strains were determined by E-test strips. The β-lactamases involved were characterized by polymerase chain reaction assays and DNA sequencing. Conjugation experiments were done and ISEcp1 elements were tested among CTX-M positive isolates. The prevalence of ESBL was 25.6% (110/430) and all ESBL-positive isolates were sensitive to imipenem and tigecycline; however, the resistance rate to gentamicin, amikacin, and ciprofloxacin was 87.3%, 10%, and 9.1%, respectively. Of these, 89.1% produced SHV, 70.9% produced TEM, and 36.4% were CTX-M-producing strains. The prevalence of ESBL SHV SHV-12 and SHV-5 was of 60% and 18.2%, respectively, and various non-ESBL SHV, including SHV-1 (5.5%), -11 (3.6%), and -85 (1.8%), was detected. However, the prevalence of CTX-M-15 and CTX-M-14 was 34.5% and 1.8%, respectively. ISEcp1 element was detected in 60% of bla(CTX-M-15) genes. All bla(CTX-M) genes were transferable; however, most of bla(SHV-12) and bla(SHV-5) were not transferable. TEM-type ESBLs were not detected in any of the isolates. This is the first description of CTX-M-14, SHV-5, SHV-11, and SHV-85 in Saudi Arabia. We have documented the dominance of K. pneumoniae SHV-12 and highlighted the emergence of CTX-M-15 in Saudi Arabia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21612509     DOI: 10.1089/mdr.2011.0011

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  19 in total

1.  Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment.

Authors:  Sibhghatulla Shaikh; Jamale Fatima; Shazi Shakil; Syed Mohd Danish Rizvi; Mohammad Amjad Kamal
Journal:  Saudi J Biol Sci       Date:  2014-08-17       Impact factor: 4.219

2.  Risk Factors for Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae Carriage Upon Pediatric Intensive Care Unit Admission.

Authors:  David X Li; Anna C Sick-Samuels; Nuntra Suwantarat; Rebecca G Same; Patricia J Simner; Pranita D Tamma
Journal:  Infect Control Hosp Epidemiol       Date:  2017-12-05       Impact factor: 3.254

3.  Whole Genome Characterization of the High-Risk Clone ST383 Klebsiella pneumoniae with a Simultaneous Carriage of blaCTX-M-14 on IncL/M Plasmid and blaCTX-M-15 on Convergent IncHI1B/IncFIB Plasmid from Egypt.

Authors:  Eva A Edward; Nelly M Mohamed; Azza S Zakaria
Journal:  Microorganisms       Date:  2022-05-26

Review 4.  β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula.

Authors:  Hosam M Zowawi; Hanan H Balkhy; Timothy R Walsh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

5.  Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131.

Authors:  Mohamed H Al-Agamy; Atef M Shibl; Mohamed M Hafez; Mohammad N Al-Ahdal; Ziad A Memish; Harish Khubnani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-01-07       Impact factor: 3.944

6.  The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia.

Authors:  Essam J Alyamani; Anamil M Khiyami; Rayan Y Booq; Majed A Majrashi; Fayez S Bahwerth; Elena Rechkina
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-01-06       Impact factor: 3.944

Review 7.  The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases.

Authors:  Sadeeq Ur Rahman; Tariq Ali; Ijaz Ali; Nazir Ahmad Khan; Bo Han; Jian Gao
Journal:  Biomed Res Int       Date:  2018-03-26       Impact factor: 3.411

8.  Incidence and molecular characterization of the extended spectrum beta lactamase-producing Escherichia coli isolated from urinary tract infections in Eastern Saudi Arabia.

Authors:  Fahad A Mashwal; Salah H El Safi; Siju K George; Ahmed A Adam; Arulanantham Z Jebakumar
Journal:  Saudi Med J       Date:  2017-07       Impact factor: 1.484

9.  Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study.

Authors:  Zeina A Kanafani; Sukayna M Fadlallah; Sarah Assaf; Khalil Anouti; Kohar Annie B Kissoyan; Jad Sfeir; Tamara Nawar; Mohamad Yasmin; Ghassan M Matar
Journal:  Antimicrob Resist Infect Control       Date:  2017-05-15       Impact factor: 4.887

10.  CTX-M-15 Positive Escherichia coli and Klebsiella pneumoniae Outbreak in the Neonatal Intensive Care Unit of a Maternity Hospital in Ha'il, Saudi Arabia.

Authors:  Mohammed Almogbel; Ahmed Altheban; Mohammed Alenezi; Khalid Al-Motair; Godfred A Menezes; Mohammed Elabbasy; Sahar Hammam; John P Hays; Mushtaq A Khan
Journal:  Infect Drug Resist       Date:  2021-07-23       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.